[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G. Clinical Trials
3 recruitingDrug
Phase 12Early Phase 11
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
Metastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
University of California, Davis30 enrolled1 locationNCT04665947
Recruiting
Phase 1
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
Metastatic Cancer
University of California, Davis40 enrolled1 locationNCT06389123
Recruiting
Phase 1
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
Metastatic Nonsmall Cell Lung Cancer
University of California, Davis40 enrolled1 locationNCT06228482